XML 39 R78.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Equity-based Compensation - Activity Related to Nonvested Restricted Stock (Details) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended 0 Months Ended 36 Months Ended
Dec. 31, 2013
Restricted Stock [Member]
Dec. 31, 2012
Restricted Stock [Member]
Dec. 31, 2011
Restricted Stock [Member]
Dec. 31, 2013
Time Vested Restricted Stock [Member]
Dec. 31, 2013
Performance Based Restricted Stock [Member]
Dec. 31, 2013
Performance Period, 2012 to 2014 [Member]
Performance Based Restricted Stock [Member]
Feb. 01, 2014
Performance Period, 2011 to 2013 [Member]
Performance Based Restricted Stock [Member]
Dec. 31, 2013
Performance Period, 2011 to 2013 [Member]
Performance Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Nonvested Balance at Beginning of Year, Restricted Shares       126,349 187,075      
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value       $ 26.19 $ 36.70      
Grants in Period       75,625 70,675      
Grants in Period, Weighted Average Grant Date Fair Value       $ 33.33 $ 42.12      
Vested in Period       (59,065) (53,118)      
Vested in Period, Weighted Average Grant Date Fair Value       $ 24.99 $ 33.14      
Forfeited in Period       (41,282) (27,832)      
Forfeited in Period, Weighted Average Grant Date Fair Value       $ 27.98 $ 39.16      
Nonvested Balance at End of Year, Restricted Shares       101,627 176,800      
Nonvested at End of Year, Weighted Average Grant Date Fair Value       $ 31.48 $ 39.54      
Number of Additional Shares To Be Granted If Maximum Perfornance Level Is Met or Exceeded           59,775    
Reduction in Share Authorization if Maximum Performance Level is Met or Exceeded         390,486 179,325    
Payout Percentage for Exceeding Performance Target               118.00%
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures             9,014  
Vested in Period, Total Fair Value $ 4.1 $ 4.0 $ 1.4          
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation $ 1.4 $ 1.4 $ 0.5